Global central banks show mixed outlook, with Fed and BoE decisions hinging on data and policy shifts.
Ravens acquire versatile pass rusher Dre'Mont Jones from Titans to bolster their defense.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Global central banks show mixed outlook, with Fed and BoE decisions hinging on data and policy shifts.
Ravens acquire versatile pass rusher Dre'Mont Jones from Titans to bolster their defense.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.